StreetInsider.com News Articles

Form S-8 GRAIL, Inc.

Thu, 12 Mar 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260312/26154076.html

Form S-8 GRAIL, Inc.

Thu, 12 Mar 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260312/26154076.html

Form S-8 GRAIL, Inc.

Thu, 12 Mar 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260312/26154076.html

Form 10-K GRAIL, Inc. For: Dec 31

Thu, 12 Mar 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260312/26153991.html

Form 10-K GRAIL, Inc. For: Dec 31

Thu, 12 Mar 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260312/26153991.html

Form 10-K GRAIL, Inc. For: Dec 31

Thu, 12 Mar 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260312/26153991.html

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

The healthcare company's board of directors selected Ofman following a succession planning process. Ofman has been appointed to GRAIL's board of directors immediately, while Ragusa will remain on the board until June 1, 2026, and serve in a senior advisory role through March 2027.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL names Josh Ofman as new CEO, replacing retiring Bob Ragusa

Thu, 12 Mar 2026 16:30:44 -0400

GRAIL Inc. (NASDAQ: GRAL) announced that Bob Ragusa will retire as chief executive officer effective June 1, 2026, with the company's president Josh Ofman appointed as his successor.

Ofman joined GRAIL in 2019 and previously spent more than 15 years at Amgen, most recently as senior vice president of global value, access and policy. He also served as

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor